- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 125643, 11 pages
Dextromethorphan Inhibits Activations and Functions in Dendritic Cells
1Institute of Biomedical Science, National Chung-Hsing University, Taichung 402, Taiwan
2Faculty of Medicine, National Yang-Ming University, Taipei 112, Taiwan
3Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung 407, Taiwan
4Laboratory of Toxicology and Pharmacology, National Institutes of Environmental, Health Sciences, Research Triangle Park, NC 27709, USA
5Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
6Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu 300, Taiwan
7Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan
8Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua 500, Taiwan
9Department of Respiratory Care, College of Health Sciences, Chang Jung Christian University, Tainan 711, Taiwan
10School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
11Department of Medical Research and Education, Taichung Veterans General Hospital, Taichung 407, Taiwan
Received 1 February 2013; Accepted 25 March 2013
Academic Editor: Beatrice Gaugler
Copyright © 2013 Der-Yuan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. M. Steinman and H. Hemmi, “Dendritic cells: translating innate to adaptive immunity,” Current Topics in Microbiology and Immunology, vol. 311, pp. 17–58, 2006.
- M. F. Lipscomb and B. J. Masten, “Dendritic cells: immune regulators in health and disease,” Physiological Reviews, vol. 82, no. 1, pp. 97–130, 2002.
- R. Thomas and P. E. Lipsky, “Dendritic cells: origin and differentiation,” Stem Cells, vol. 14, no. 2, pp. 196–206, 1996.
- C. Watts, M. A. West, and R. Zaru, “TLR signalling regulated antigen presentation in dendritic cells,” Current Opinion in Immunology, vol. 22, no. 1, pp. 124–130, 2010.
- Y. Yanagawa, N. Iijima, K. Iwabuchi, and K. Onoé, “Activation of extracellular signal-related kinase by TNF-α controls the maturation and function of murine dendritic cells,” Journal of Leukocyte Biology, vol. 71, no. 1, pp. 125–132, 2002.
- P. Hubert, N. Jacobs, J. H. Caberg, J. Boniver, and P. Delvenne, “The cross-talk between dendritic and regulatory T cells: good or evil?” Journal of Leukocyte Biology, vol. 82, no. 4, pp. 781–794, 2007.
- A. G. Thompson and R. Thomas, “Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease,” Immunology and Cell Biology, vol. 80, no. 6, pp. 509–519, 2002.
- M. Menges, S. Rößner, C. Voigtländer et al., “Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 15–21, 2002.
- D. L. Roelen, D. H. Schuurhuis, D. E. M. van den Boogaardt et al., “Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells,” Transplantation, vol. 76, no. 11, pp. 1608–1615, 2003.
- M. D. Elftman, C. C. Norbury, R. H. Bonneau, and M. E. Truckenmiller, “Corticosterone impairs dendritic cell maturation and function,” Immunology, vol. 122, no. 2, pp. 279–290, 2007.
- Z. Y. Wang, A. Morinobu, S. Kawano, J. Saegusa, B. Wang, and S. Kumagai, “Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes,” Clinical and Experimental Rheumatology, vol. 20, no. 5, pp. 683–688, 2002.
- B. M. Kirsch, M. Zeyda, K. Stuhlmeier et al., “The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function,” Arthritis research & therapy, vol. 7, no. 3, pp. R694–R703, 2005.
- P. P. Wadia, N. D. Herrera, M. M. Abecassis, and A. R. Tambur, “Mycophenolic acid inhibits maturation and function of human dendritic cells and B cells,” Human Immunology, vol. 70, no. 9, pp. 692–700, 2009.
- J. Frikeche, T. Simon, E. Brissot, M. Grégoire, and B. Gaugler M Mohty, “Impact of valproic acid on dendritic cells function,” Immunobiology, vol. 217, no. 7, pp. 704–710, 2012.
- J. Frikeche, Z. Peric, E. Brissot, M. Grégoire, B. Gaugler, and M. Mohty, “Impact of HDAC inhibitors on dendritic cell functions,” Experimental Hematology, vol. 40, no. 10, pp. 783–791, 2012.
- C. C. Wang, Y. M. Lee, H. P. Wei, C. C. Chu, and M. H. Yen, “Dextromethorphan prevents circulatory failure in rats with endotoxemia,” Journal of Biomedical Science, vol. 11, no. 6, pp. 739–747, 2004.
- O. V. Chechneva, F. Mayrhofer, D. J. Daugherty, D. E. Pleasure, J. S. Hong, and W. Deng, “Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord,” Neurobiology of Disease, vol. 44, no. 1, pp. 63–72, 2011.
- M. H. Li, Y. H. Luo, C. F. Lin et al., “Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group A streptococcal sepsis,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 3, pp. 967–973, 2011.
- S. L. Liu, Y. H. Li, G. Y. Shi et al., “Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice,” Cardiovascular Research, vol. 82, no. 1, pp. 161–169, 2009.
- P. Y. Liu, C. C. Lin, W. C. Tsai et al., “Treatment with dextromethorphan improves endothelial function, inflammation and oxidative stress in male heavy smokers,” Journal of Thrombosis and Haemostasis, vol. 6, no. 10, pp. 1685–1692, 2008.
- S. T. Wang, C. C. Chang, M. C. Yen et al., “RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency,” Gene Therapy, vol. 18, no. 4, pp. 372–383, 2011.
- C. C. Lin, Y. L. Yu, C. C. Shih et al., “A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells,” Cancer Immunology, Immunotherapy, vol. 60, no. 7, pp. 1019–1027, 2011.
- C. S. Wu, Y. J. Chen, J. J. Chen et al., “Terpinen-4-ol induces apoptosis in human nonsmall cell lung cancer in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 818261, 13 pages, 2012.
- R. M. Steinman and J. Banchereau, “Taking dendritic cells into medicine,” Nature, vol. 449, no. 7161, pp. 419–426, 2007.
- V. Verhasselt, W. Vanden Berghe, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman, “N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition,” Journal of Immunology, vol. 162, no. 5, pp. 2569–2574, 1999.
- M. Rescigno, M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi-Castagnoli, “Dendritic cell survival and maturation are regulated by different signaling pathways,” Journal of Experimental Medicine, vol. 188, no. 11, pp. 2175–2180, 1998.
- J. F. Arrighi, M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser, “A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers,” Journal of Immunology, vol. 166, no. 6, pp. 3837–3845, 2001.
- H. An, Y. Yu, M. Zhang et al., “Involvement of ERK, p38 and NF-κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells,” Immunology, vol. 106, no. 1, pp. 38–45, 2002.
- T. Kawai and S. Akira, “Signaling to NF-κB by Toll-like receptors,” Trends in Molecular Medicine, vol. 13, no. 11, pp. 460–469, 2007.
- S. J. Jiang, S. Y. Hsu, C. R. Deng et al., “Dextromethorphan attenuates LPS-induced adhesion molecule expression in human endothelial cells,” Microcirculation, vol. 20, no. 2, pp. 190–201, 2013.
- J. Brown, H. Wang, G. N. Hajishengallis, and M. Martin, “TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk,” Journal of Dental Research, vol. 90, no. 4, pp. 417–427, 2011.
- A. Oeckinghaus, M. S. Hayden, and S. Ghosh, “Crosstalk in NF-κB signaling pathways,” Nature Immunology, vol. 12, no. 8, pp. 695–708, 2011.
- J. L. Luo, H. Kamata, and M. Karin, “The anti-death machinery in IKK/NF-κB signaling,” Journal of Clinical Immunology, vol. 25, no. 6, pp. 541–550, 2005.
- V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” The American Journal of Physiology, vol. 279, no. 6, pp. L1005–L1028, 2000.
- T. C. Wu, C. Y. Chao, S. J. Lin, and J. W. Chen, “Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension,” PLoS One, vol. 7, no. 9, Article ID e46067, 2012.
- G. Li, G. Cui, N. S. Tzeng et al., “Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage,” FASEB Journal, vol. 19, no. 6, pp. 489–496, 2005.
- W. Zhang, T. Wang, L. Qin et al., “Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase,” FASEB Journal, vol. 18, no. 3, pp. 589–591, 2004.
- J. H. Song and J. Z. Yeh, “Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells,” Neuroscience Letters, vol. 516, no. 1, pp. 94–98, 2012.
- A. Savina, C. Jancic, S. Hugues et al., “NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells,” Cell, vol. 126, no. 1, pp. 205–218, 2006.
- M. Vulcano, S. Dusi, D. Lissandrini et al., “Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells,” Journal of Immunology, vol. 173, no. 9, pp. 5749–5756, 2004.
- J. Zhu, H. Yamane, and W. E. Paul, “Differentiation of effector CD4+ T cell populations,” Annual Review of Immunology, vol. 28, pp. 445–489, 2010.
- W. T. Watford, M. Moriguchi, A. Morinobu, and J. J. O'Shea, “The biology of IL-12: coordinating innate and adaptive immune responses,” Cytokine and Growth Factor Reviews, vol. 14, no. 5, pp. 361–368, 2003.
- K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume, “Interferon-γ: an overview of signals, mechanisms and functions,” Journal of Leukocyte Biology, vol. 75, no. 2, pp. 163–189, 2004.
- R. B. Moss, T. Moll, M. El-Kalay et al., “Th1/Th2 cells in inflammatory disease states: therapeutic implications,” Expert Opinion on Biological Therapy, vol. 4, no. 12, pp. 1887–1896, 2004.
- G. M. Barton and R. Medzhitov, “Control of adaptive immune responses by Toll-like receptors,” Current Opinion in Immunology, vol. 14, pp. 380–383, 2002.
- H. Hammad, H. H. Smits, C. Ratajczak et al., “Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22,” European Cytokine Network, vol. 14, no. 4, pp. 219–228, 2003.
- A. Galy, I. Christopherson, G. Ferlazzo, G. Liu, H. Spits, and K. Georgopoulos, “Distinct signals control the hematopoiesis of lymphoid-related dendritic cells,” Blood, vol. 95, no. 1, pp. 128–137, 2000.
- C. Orabona and U. Grohmann, “Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond,” Methods in Molecular Biology, vol. 677, pp. 269–280, 2011.
- D. J. Chung, M. Rossi, E. Romano et al., “Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells,” Blood, vol. 114, no. 3, pp. 555–563, 2009.
- R. Kushwah and J. Hu, “Role of dendritic cells in the induction of regulatory T cells,” Cell and Bioscience, vol. 1, no. 1, pp. 1–20, 2011.
- M. K. Levings, S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M. G. Roncarolo, “Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells,” Blood, vol. 105, no. 3, pp. 1162–1169, 2005.
- C. Haase, T. N. Jørgensen, and B. K. Michelsen, “Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo,” Immunology, vol. 107, no. 4, pp. 489–499, 2002.
- A. Bai, N. Lu, Y. Guo, Z. Liu, J. Chen, and Z. Peng, “All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis,” Journal of Leukocyte Biology, vol. 86, no. 4, pp. 959–969, 2009.
- J. Banchereau, V. Pascual, and A. O. 'Garra, “From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines,” Nature Immunology, vol. 13, no. 10, pp. 925–931, 2012.
- D. A. Capon, F. Bochner, N. Kerry, G. Mikus, C. Danz, and A. A. Somogyi, “The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans,” Clinical Pharmacology and Therapeutics, vol. 60, no. 3, pp. 295–307, 1996.
- G. K. Steinberg, T. E. Bell, and M. A. Yenari, “Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients,” Journal of Neurosurgery, vol. 84, no. 5, pp. 860–866, 1996.
- M. Colonna, B. Pulendran, and A. Iwasaki, “Dendritic cells at the host-pathogen interface,” Nature Immunology, vol. 7, no. 2, pp. 117–120, 2006.
- A. Manickam, M. Sivanandham, and I. L. Tourkova, “Immunological role of dendritic cells in cervical cancer,” Advances in Experimental Medicine and Biology, vol. 601, pp. 155–162, 2007.
- B. Pulendran, “Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors,” Immunologic Research, vol. 29, no. 1–3, pp. 187–196, 2004.